Biondo Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-261,205	Closed	-$4.25M	–	77
2022 Q1	$4.25M	Sell	261,205 -8,375	-3%	-$136K	0.75%	40
2021 Q4	$3.73M	Buy	269,580 +2,100	+0.8%	+$29.1K	0.62%	43
2021 Q3	$3.84M	Buy	267,480 +1,640	+0.6%	+$23.6K	0.66%	45
2021 Q2	$4.2M	Buy	+265,840	New	+$4.2M	0.72%	45